Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis.

Kass DJ, Nouraie M, Glassberg MK, Ramreddy N, Fernandez K, Harlow L, Zhang Y, Chen J, Kerr GS, Reimold AM, England BR, Mikuls TR, Gibson KF, Dellaripa PF, Rosas IO, Oddis CV, Ascherman DP.

Arthritis Rheumatol. 2020 Mar;72(3):409-419. doi: 10.1002/art.41123. Epub 2020 Feb 5. Erratum in: Arthritis Rheumatol. 2020 Apr;72(4):597.

PMID:
31532072
2.

Post-traumatic stress disorder and serum cytokine and chemokine concentrations in patients with rheumatoid arthritis.

Maloley PM, England BR, Sayles H, Thiele GM, Michaud K, Sokolove J, Cannon GW, Reimold AM, Kerr GS, Baker JF, Caplan L, Case AJ, Mikuls TR.

Semin Arthritis Rheum. 2019 Oct;49(2):229-235. doi: 10.1016/j.semarthrit.2019.02.002. Epub 2019 Feb 8.

PMID:
30777365
4.

Body Mass Index, Weight Loss, and Cause-Specific Mortality in Rheumatoid Arthritis.

England BR, Baker JF, Sayles H, Michaud K, Caplan L, Davis LA, Cannon GW, Sauer BC, Solow EB, Reimold AM, Kerr GS, Mikuls TR.

Arthritis Care Res (Hoboken). 2018 Jan;70(1):11-18. doi: 10.1002/acr.23258. Epub 2017 Dec 6.

5.

Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.

Davis LS, Reimold AM.

Rheumatology (Oxford). 2017 Apr 1;56(suppl_1):i100-i113. doi: 10.1093/rheumatology/kew417. Review.

6.

Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study.

Kavanaugh A, Mease PJ, Reimold AM, Tahir H, Rech J, Hall S, Geusens P, Wang Z, Pricop L, Mpofu S; FUTURE-1 Study Group.

Arthritis Care Res (Hoboken). 2017 Mar;69(3):347-355. doi: 10.1002/acr.23111.

7.

Increased inflammation and disease activity among current cigarette smokers with rheumatoid arthritis: a cross-sectional analysis of US veterans.

Sokolove J, Wagner CA, Lahey LJ, Sayles H, Duryee MJ, Reimold AM, Kerr G, Robinson WH, Cannon GW, Thiele GM, Mikuls TR.

Rheumatology (Oxford). 2016 Nov;55(11):1969-1977. Epub 2016 Jul 31.

8.

Associations of Circulating Cytokines and Chemokines With Cancer Mortality in Men With Rheumatoid Arthritis.

England BR, Sokolove J, Robinson WH, Thiele GM, Ganti AK, Sayles H, Michaud K, Caplan L, Davis LA, Cannon GW, Sauer B, Singh N, Blair Solow E, Reimold AM, Kerr GS, Schwab P, Baker JF, Mikuls TR.

Arthritis Rheumatol. 2016 Oct;68(10):2394-402. doi: 10.1002/art.39735.

9.

Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis.

England BR, Sayles H, Michaud K, Caplan L, Davis LA, Cannon GW, Sauer BC, Solow EB, Reimold AM, Kerr GS, Schwab P, Baker JF, Mikuls TR.

Arthritis Care Res (Hoboken). 2016 Jan;68(1):36-45. doi: 10.1002/acr.22642.

10.

Vascular calcifications on hand radiographs in rheumatoid arthritis and associations with autoantibodies, cardiovascular risk factors and mortality.

Solow EB, Yu F, Thiele GM, Sokolove J, Robinson WH, Pruhs ZM, Michaud KD, Erickson AR, Sayles H, Kerr GS, Gaffo AL, Caplan L, Davis LA, Cannon GW, Reimold AM, Baker J, Schwab P, Anderson DR, Mikuls TR.

Rheumatology (Oxford). 2015 Sep;54(9):1587-95. doi: 10.1093/rheumatology/kev027. Epub 2015 Apr 7.

11.

Nonpharmacologic therapies in spondyloarthritis.

Reimold AM, Chandran V.

Best Pract Res Clin Rheumatol. 2014 Oct;28(5):779-92. doi: 10.1016/j.berh.2014.10.003. Epub 2014 Nov 1. Review.

PMID:
25488784
12.

Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.

Gonzalez SM, Payne JB, Yu F, Thiele GM, Erickson AR, Johnson PG, Schmid MJ, Cannon GW, Kerr GS, Reimold AM, Sokolove J, Robinson WH, Mikuls TR.

J Periodontol. 2015 Feb;86(2):222-31. doi: 10.1902/jop.2014.140425. Epub 2014 Oct 9.

PMID:
25299390
13.

Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis.

Sokolove J, Johnson DS, Lahey LJ, Wagner CA, Cheng D, Thiele GM, Michaud K, Sayles H, Reimold AM, Caplan L, Cannon GW, Kerr G, Mikuls TR, Robinson WH.

Arthritis Rheumatol. 2014 Apr;66(4):813-21. doi: 10.1002/art.38307.

14.

Association of rheumatoid arthritis susceptibility gene with lipid profiles in patients with rheumatoid arthritis.

Davis LA, Whitfield E, Cannon GW, Wolff RK, Johnson DS, Reimold AM, Kerr GS, Richards JS, Mikuls TR, Caplan L.

Rheumatology (Oxford). 2014 Jun;53(6):1014-21.

15.

Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis.

Davis LA, Polk B, Mann A, Wolff RK, Kerr GS, Reimold AM, Cannon GW, Mikuls TR, Caplan L.

Clin Exp Rheumatol. 2014 May-Jun;32(3):324-32. Epub 2014 Jan 20.

16.

SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature.

Becker AM, Dao KH, Han BK, Kornu R, Lakhanpal S, Mobley AB, Li QZ, Lian Y, Wu T, Reimold AM, Olsen NJ, Karp DR, Chowdhury FZ, Farrar JD, Satterthwaite AB, Mohan C, Lipsky PE, Wakeland EK, Davis LS.

PLoS One. 2013 Jun 24;8(6):e67003. doi: 10.1371/journal.pone.0067003. Print 2013.

17.

Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis.

Davis LA, Cannon GW, Pointer LF, Haverhals LM, Wolff RK, Mikuls TR, Reimold AM, Kerr GS, Richards JS, Johnson DS, Valuck R, Prochazka A, Caplan L.

J Rheumatol. 2013 Jun;40(6):809-17. doi: 10.3899/jrheum.121012. Epub 2013 Apr 1.

18.

Validation of Diagnostic and Procedural Codes for Identification of Acute Cardiovascular Events in US Veterans with Rheumatoid Arthritis.

Davis LA, Mann A, Cannon GW, Mikuls TR, Reimold AM, Caplan L.

EGEMS (Wash DC). 2014 Jan 14;1(3):1023. doi: 10.13063/2327-9214.1023. eCollection 2013.

19.

Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis.

Richards JS, Cannon GW, Hayden CL, Amdur RL, Lazaro D, Mikuls TR, Reimold AM, Caplan L, Johnson DS, Schwab P, Cherascu BN, Kerr GS.

Arthritis Care Res (Hoboken). 2012 Dec;64(12):1864-70. doi: 10.1002/acr.21777.

20.

Body mass index and the rheumatoid arthritis swollen joint count: an observational study.

Caplan L, Davis LA, Bright CM, Kerr GS, Lazaro DM, Khan NA, Richards JS, Johnson DS, Cannon GW, Reimold AM, Mikuls TR.

Arthritis Care Res (Hoboken). 2013 Jan;65(1):101-6. doi: 10.1002/acr.21734.

21.

The role of adalimumab in rheumatic and autoimmune disorders: comparison with other biologic agents.

Reimold AM.

Open Access Rheumatol. 2012 May 3;4:33-47. eCollection 2012. Review.

22.

Soluble CD14 and CD14 polymorphisms in rheumatoid arthritis.

Mikuls TR, LeVan TD, Sayles H, Yu F, Caplan L, Cannon GW, Kerr GS, Reimold AM, Johnson DS, Thiele GM.

J Rheumatol. 2011 Dec;38(12):2509-16. doi: 10.3899/jrheum.110378. Epub 2011 Sep 15.

PMID:
21921097
23.

Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice.

Cannon GW, Mikuls TR, Hayden CL, Ying J, Curtis JR, Reimold AM, Caplan L, Kerr GS, Richards JS, Johnson DS, Sauer BC.

Arthritis Care Res (Hoboken). 2011 Dec;63(12):1680-90. doi: 10.1002/acr.20629.

24.

Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional study.

Mikuls TR, Gould KA, Bynoté KK, Yu F, Levan TD, Thiele GM, Michaud KD, O'Dell JR, Reimold AM, Hooker R, Caplan L, Johnson DS, Kerr G, Richards JS, Cannon GW, Criswell LA, Noble JA, Bridges SL Jr, Hughes L, Gregersen PK.

Arthritis Res Ther. 2010;12(6):R213. doi: 10.1186/ar3190. Epub 2010 Nov 18.

25.

Dual-energy X-ray absorptiometry and evaluation of the osteoporosis self-assessment tool in men with rheumatoid arthritis.

Richards JS, Peng J, Amdur RL, Mikuls TR, Hooker RS, Michaud K, Reimold AM, Cannon GW, Caplan L, Johnson D, Hines AE, Kerr GS.

J Clin Densitom. 2009 Oct-Dec;12(4):434-40. doi: 10.1016/j.jocd.2009.06.003. Epub 2009 Sep 23.

PMID:
19775920
26.

Poor to modest agreement between rheumatoid arthritis response measures in clinical practice.

Michaud K, Mikuls TR, Call SE, Reimold AM, Hooker R, Kerr GS, Richards JS, Caplan L, Cannon GW.

Clin Exp Rheumatol. 2009 Jul-Aug;27(4):633-40.

PMID:
19772796
27.

Recognizing concomitant lupus enteritis and lupus cystitis.

Kornu R, Oliver QZ, Reimold AM.

J Clin Rheumatol. 2008 Aug;14(4):226-9. doi: 10.1097/RHU.0b013e318181a8ec.

PMID:
18766123
28.

Acute coronary syndrome after infliximab infusion.

Abedin M, Scheurich D, Reimold SC, Reimold AM.

Cardiol Rev. 2006 Jan-Feb;14(1):50-2.

PMID:
16371767
29.

Arrested natural killer cell development associated with transgene insertion into the Atf2 locus.

Kim S, Song YJ, Higuchi DA, Kang HP, Pratt JR, Yang L, Hong CM, Poursine-Laurent J, Iizuka K, French AR, Sunwoo JB, Ishii S, Reimold AM, Yokoyama WM.

Blood. 2006 Feb 1;107(3):1024-30. Epub 2005 Oct 13.

30.

TNFalpha as therapeutic target: new drugs, more applications.

Reimold AM.

Curr Drug Targets Inflamm Allergy. 2002 Dec;1(4):377-92. Review.

PMID:
14561184
31.

New indications for treatment of chronic inflammation by TNF-alpha blockade.

Reimold AM.

Am J Med Sci. 2003 Feb;325(2):75-92.

PMID:
12589232
32.
33.

Plasma cell differentiation requires the transcription factor XBP-1.

Reimold AM, Iwakoshi NN, Manis J, Vallabhajosyula P, Szomolanyi-Tsuda E, Gravallese EM, Friend D, Grusby MJ, Alt F, Glimcher LH.

Nature. 2001 Jul 19;412(6844):300-7.

PMID:
11460154
34.

Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant mice.

Reimold AM, Kim J, Finberg R, Glimcher LH.

Int Immunol. 2001 Feb;13(2):241-8.

PMID:
11157857
35.

Amino acids control mammalian gene transcription: activating transcription factor 2 is essential for the amino acid responsiveness of the CHOP promoter.

Bruhat A, Jousse C, Carraro V, Reimold AM, Ferrara M, Fafournoux P.

Mol Cell Biol. 2000 Oct;20(19):7192-204.

36.

A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo.

Tsai EY, Falvo JV, Tsytsykova AV, Barczak AK, Reimold AM, Glimcher LH, Fenton MJ, Gordon DC, Dunn IF, Goldfeld AE.

Mol Cell Biol. 2000 Aug;20(16):6084-94.

37.

An essential role in liver development for transcription factor XBP-1.

Reimold AM, Etkin A, Clauss I, Perkins A, Friend DS, Zhang J, Horton HF, Scott A, Orkin SH, Byrne MC, Grusby MJ, Glimcher LH.

Genes Dev. 2000 Jan 15;14(2):152-7.

38.

Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells.

Wen XY, Stewart AK, Sooknanan RR, Henderson G, Hawley TS, Reimold AM, Glimcher LH, Baumann H, Malek LT, Hawley RG.

Int J Oncol. 1999 Jul;15(1):173-8.

PMID:
10375612
39.

Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: opposite effects of interferon and methimazole.

Montani V, Shong M, Taniguchi SI, Suzuki K, Giuliani C, Napolitano G, Saito J, Saji M, Fiorentino B, Reimold AM, Singer DS, Kohn LD.

Endocrinology. 1998 Jan;139(1):290-302.

PMID:
9421427
40.

Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.

Montani V, Taniguchi SI, Shong M, Suzuki K, Ohmori M, Giuliani C, Napolitano G, Saji M, Fiorentino B, Reimold AM, Ting JP, Kohn LD, Singer DS.

Endocrinology. 1998 Jan;139(1):280-9.

PMID:
9421426
41.

Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1.

Reimold AM, Ponath PD, Li YS, Hardy RR, David CS, Strominger JL, Glimcher LH.

J Exp Med. 1996 Feb 1;183(2):393-401.

42.

Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice.

Reimold AM, Grusby MJ, Kosaras B, Fries JW, Mori R, Maniwa S, Clauss IM, Collins T, Sidman RL, Glimcher MJ, Glimcher LH.

Nature. 1996 Jan 18;379(6562):262-5.

PMID:
8538792
43.

Tachyphylaxis of intravenous immunoglobulin in refractory inflammatory myopathy.

Reimold AM, Weinblatt ME.

J Rheumatol. 1994 Jun;21(6):1144-6.

PMID:
7932431
44.

Transforming growth factor beta 1 repression of the HLA-DR alpha gene is mediated by conserved proximal promoter elements.

Reimold AM, Kara CJ, Rooney JW, Glimcher LH.

J Immunol. 1993 Oct 15;151(8):4173-82.

PMID:
8409394
45.

Novel leukaemogenic retroviruses isolated from cell line derived from spontaneous AKR tumour.

Pedersen FS, Crowther RL, Tenney DY, Reimold AM, Haseltine WA.

Nature. 1981 Jul 9;292(5819):167-70. No abstract available.

PMID:
6264322

Supplemental Content

Loading ...
Support Center